EP0970065A4 - Antibiotiques et leur procede de preparation - Google Patents

Antibiotiques et leur procede de preparation

Info

Publication number
EP0970065A4
EP0970065A4 EP97951517A EP97951517A EP0970065A4 EP 0970065 A4 EP0970065 A4 EP 0970065A4 EP 97951517 A EP97951517 A EP 97951517A EP 97951517 A EP97951517 A EP 97951517A EP 0970065 A4 EP0970065 A4 EP 0970065A4
Authority
EP
European Patent Office
Prior art keywords
antibiotics
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97951517A
Other languages
German (de)
English (en)
Other versions
EP0970065A1 (fr
Inventor
William L Truett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0970065A1 publication Critical patent/EP0970065A1/fr
Publication of EP0970065A4 publication Critical patent/EP0970065A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
EP97951517A 1997-11-29 1997-11-29 Antibiotiques et leur procede de preparation Withdrawn EP0970065A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/022012 WO1999028308A1 (fr) 1997-11-29 1997-11-29 Antibiotiques et leur procede de preparation

Publications (2)

Publication Number Publication Date
EP0970065A1 EP0970065A1 (fr) 2000-01-12
EP0970065A4 true EP0970065A4 (fr) 2001-03-07

Family

ID=22262179

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97951517A Withdrawn EP0970065A4 (fr) 1997-11-29 1997-11-29 Antibiotiques et leur procede de preparation

Country Status (2)

Country Link
EP (1) EP0970065A4 (fr)
WO (1) WO1999028308A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS20050006A (en) * 2002-07-08 2007-09-21 Glaxo Smith Kline Istraživački Centar Zagreb D.O.O., Novel compounds,compositions as carriers for steroid/non- steroid anti-inflammatory,antineoplastic and antiviral active molecules
JP2005536488A (ja) 2002-07-08 2005-12-02 プリヴァ−イストラジヴァキ・インスティトゥ・ディー・オー・オー 新規な非ステロイド抗炎症物質、組成物、およびその使用方法
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
EP2862569A1 (fr) 2011-09-09 2015-04-22 Cubist Pharmaceuticals, Inc. Procédés pour traiter des infections intrapulmonaires
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
KR102226197B1 (ko) 2013-03-15 2021-03-11 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
WO2015035376A2 (fr) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
US10232345B2 (en) 2015-02-12 2019-03-19 Arizona Board Of Regents On Behalf Of Arizona State University Aminoglycoside hydrogel microbeads and macroporous gels with chemical crosslink, method of preparation and use thereof
CN106124683B (zh) * 2016-08-26 2017-11-28 中国兽医药品监察所 一种同时检测兽药中多种抗菌成分的方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0296573A2 (fr) * 1987-06-22 1988-12-28 F. Hoffmann-La Roche Ag Nucléosides, leur préparation et compositions pharmaceutiques
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5281703A (en) * 1991-10-01 1994-01-25 Procter & Gamble Pharmaceuticals, Inc. Process for making antimicrobial quinolonyl lactams
US5693791A (en) * 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0296573A2 (fr) * 1987-06-22 1988-12-28 F. Hoffmann-La Roche Ag Nucléosides, leur préparation et compositions pharmaceutiques
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5281703A (en) * 1991-10-01 1994-01-25 Procter & Gamble Pharmaceuticals, Inc. Process for making antimicrobial quinolonyl lactams
US5693791A (en) * 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9928308A1 *

Also Published As

Publication number Publication date
EP0970065A1 (fr) 2000-01-12
WO1999028308A1 (fr) 1999-06-10

Similar Documents

Publication Publication Date Title
AP9901444A0 (en) Erythrommycins and process for their preparation
HUP9800208A3 (en) Omega-cycloalkyl-prostaglandin e2-derivatives and process for preparing them
EP0960934A4 (fr) Nouvelle phytase et son procede de preparation
GB9701251D0 (en) Process
HUP9900935A3 (en) Antifungic and antibacterial peptide and process for preparation
PL326150A1 (en) Cephalosporinic antibiotics
HUP0003614A3 (en) Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
EP0970065A4 (fr) Antibiotiques et leur procede de preparation
GB2330556B (en) Process
EP0890599A4 (fr) Polyorganosiloxazanes et leur procede de preparation
GB9710990D0 (en) Modification process
EP1001035A4 (fr) Nouveaux antibiotiques rk-1061 et procede pour leur preparation
AUPO752297A0 (en) Manufacturing process and apparatus
HUP0002717A3 (en) 13-deoxyanthracycline derivatives and processes for preparing them
GB9700331D0 (en) Process
HK1025951A1 (en) Cephalonsporin crystals and process for their preparation
HK1026703A1 (en) Novel substance ft-0554 and process for producing the same
PL319673A1 (en) Biphenoles preparation process
GB9610666D0 (en) Milk-shakes and process for making them
HUP9801594A3 (en) Novel seco-azalides and process for preparing them
EP1013277A4 (fr) Preparations lyophilisees et procede de production
NZ332994A (en) Iron-casein complex and process for preparing the same
HUP9601521A2 (en) Substituted quinoline-intermediates and process for preparation the same
HUP9601520A2 (en) Substituted quinoline-intermediates and process for preparation the same
GB9700851D0 (en) Dihydrophenanthrenone derivatives and process for their preparation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990827

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE GB

A4 Supplementary search report drawn up and despatched

Effective date: 20010122

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE GB

17Q First examination report despatched

Effective date: 20020923

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030404